Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial-Reference-Cited by-同舟云学术

Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial

Author:

Miyata Hisatsugu¹,Takahashi Masayoshi²,Murai Yoshiyuki²,Tsuneyoshi Kana³,Hayashi Takako⁴^ORCID,Meulien Didier⁵,Sørensen Per⁶,Higuchi Susumu⁷

Affiliation:

1. Department of PsychiatryJikei University School of Medicine Tokyo Japan

2. Department of Clinical ManagementClinical Development Headquarters, Otsuka Pharmaceutical Co., Ltd. Tokyo Japan

3. Department of BiometricsClinical Development Headquarters, Otsuka Pharmaceutical Co., Ltd. Osaka Japan

4. Medical Affairs, Otsuka Pharmaceutical Co., Ltd. Tokyo Japan

5. Clinical Research and Development – NeurologyH. Lundbeck SAS, Issy‐les‐Moulineaux Paris France

6. Global Analytics, H. Lundbeck Valby Denmark

7. National Hospital Organization, Kurihama Medical and Addiction Center Japan

Funder

Otsuka Pharmaceutical

H. Lundbeck A/S

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine,General Neuroscience

Link

Reference34 articles.

1. World Health Organisation.Global status report on alcohol and health. WHO Press Geneva 2014.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献